Published in Women's Health Weekly, August 17th, 2006
The company shared its findings from a Phase II clinical trial in women at a symposium held during the 10th International Conference on Alzheimer's Disease and Related Disorders, presented by the Alzheimer's Association. This report expanded on the Phase II data presented in Geneva, Switzerland in April by Dr. Brian Reynolds, director of medical and scientific information for Voyager.
"Women treated with leuprolide acetate and the current standard of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.